InsiderPulseNo transactions found.
| Date | Member | Chamber | Type | Amount |
|---|---|---|---|---|
| 2023-03-31 | Daniel Goldman(D-NY10) | house | Sale | $1,001 - $15,000 |
| 2023-02-27 | Daniel Goldman(D-NY10) | house | Purchase | $1,001 - $15,000 |
No financial data available for OLYMY.
Company may not file with SEC or CIK is unresolved.
Olympus’ Endoluminal Robotics Distribution Deal Could Be A Game Changer For Olympus (TSE:7733)
Olympus Signs Global Distribution Agreement with EndoRobotics, Adds Robot-Assisted Technologies to EndoTherapy Portfolio
Olympus and Canon Introduce the Aplio i800 EUS Premium Ultrasound System in the U.S.
Olympus Corporation 2026 Q3 - Results - Earnings Call Presentation
Olympus Corporation (OLYMY) Q3 2026 Earnings Call Transcript
Disposable Endoscope Analysis Report 2025: A $4.95 Billion Market by 2029 - Aging Population and Growing Healthcare Expenditure Accelerate Shift Toward Disposable Endoscopic Solutions
EAGLE Trial Shows Olympus(R) CADDIE(TM) AI Solution Aids in the Detection of High-Risk and Hard-to-Detect Colorectal Lesions
Olympus Corporation (OLYMY) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
Olympus Corporation (OLYMY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Olympus launches second VC fund with $150m commitment
Should Olympus’ PolyLoop Recall and VIABIL Deal Reshape the Medtech Story for Olympus (TSE:7733) Investors?
Olympus, Gore, and ConMed Announce Transition of Commercial Support for the GORE® VIABIL® Biliary Endoprosthesis in the United States